Browse diseases

…Introduction Women with systemic lupus erythematosus (SLE) have increased prevalence of precancer cervical squamous …

…e risk of subsequent acute care utilisation among patients with SLE. Future studies should examine the effectiveness of CGA measure…

…Background and Importance Systemic lupus erythematosus (SLE) is a rare disease with highly variable manifestations. Ne…

…resholds for entry and improvement, will be adopted to classify haemolytic anaemia treatment response in a novel multi-domain outcome measure for …

…nifrolumab and belimumab are both approved for the treatment of systemic lupus erythematosus (SLE), their comparative infection-related safety profiles in r…

…to evaluate potential predictors of flares in primarily Mestizo SLE patients after they had achieved remission.Methods Data from a …

… curve (AUC) analysis based on physician intent-to-treat (ITT). SLE Responder Index-4 (SRI-4) was applied and compared with the ASS…

…d a long duration is attainable for at least some patients with SLE. The degree to which this occurs in the global patient populati…

…y; p=0.012), and all cases occurred at proteinuria >300 mg/day. Proliferative LN was associated with higher clinical SLEDAI scores, higher anti–…

…t LBA: 01:38 Table 1Demographic and clinical characteristics of SLE patientsConclusions In this real-world cohort, belimumab treatm…

…ed between 2014 and 2024. Eligible studies included adults with SLE who received interventions delivered or co-delivered by nurses …

…s on definitions of remission in lupus arthritis, hematological lupus, cardiopulmonary lupus, and CNS lupus. For other organ systems …